Your browser doesn't support javascript.
loading
Twenty-year economic impacts of deworming.
Hamory, Joan; Miguel, Edward; Walker, Michael; Kremer, Michael; Baird, Sarah.
Afiliación
  • Hamory J; Department of Economics, University of Oklahoma, Norman, OK 73072.
  • Miguel E; Department of Economics, University of California, Berkeley, CA 94720.
  • Walker M; Center for Effective Global Action, University of California, Berkeley, CA 94720.
  • Kremer M; The National Bureau of Economic Research, Cambridge, MA 02138.
  • Baird S; Center for Effective Global Action, University of California, Berkeley, CA 94720.
Proc Natl Acad Sci U S A ; 118(14)2021 04 06.
Article en En | MEDLINE | ID: mdl-33790017
ABSTRACT
Estimating the impact of child health investments on adult living standards entails multiple methodological challenges, including the lack of experimental variation in health status, an inability to track individuals over time, and accurately measuring living standards and productivity in low-income settings. This study exploits a randomized school health intervention that provided deworming treatment to Kenyan children, and uses longitudinal data to estimate impacts on economic outcomes up to 20 y later. The effective respondent tracking rate was 84%. Individuals who received two to three additional years of childhood deworming experienced a 14% gain in consumption expenditures and 13% increase in hourly earnings. There are also shifts in sectors of residence and employment treatment group individuals are 9% more likely to live in urban areas, and experience a 9% increase in nonagricultural work hours. Most effects are concentrated among males and older individuals. The observed consumption and earnings benefits, together with deworming's low cost when distributed at scale, imply that a conservative estimate of its annualized social internal rate of return is 37%, a high return by any standard.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Costo de Enfermedad / Helmintiasis / Antihelmínticos Tipo de estudio: Clinical_trials / Guideline / Health_economic_evaluation Límite: Adolescent / Adult / Child / Humans País/Región como asunto: Africa Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2021 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Costo de Enfermedad / Helmintiasis / Antihelmínticos Tipo de estudio: Clinical_trials / Guideline / Health_economic_evaluation Límite: Adolescent / Adult / Child / Humans País/Región como asunto: Africa Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2021 Tipo del documento: Article